中华皮肤科杂志
中華皮膚科雜誌
중화피부과잡지
Chinese Journal of Dermatology
2013年
5期
317-319
,共3页
陈立新%王蕊%尤聪%刘志超%王敬%李卓然%刘原君%刘全忠
陳立新%王蕊%尤聰%劉誌超%王敬%李卓然%劉原君%劉全忠
진립신%왕예%우총%류지초%왕경%리탁연%류원군%류전충
衣原体,沙眼%治疗结果%培养技术%微生物敏感性试验
衣原體,沙眼%治療結果%培養技術%微生物敏感性試驗
의원체,사안%치료결과%배양기술%미생물민감성시험
Chlamydia trachomatis%Treatment outcomes%Culture techniques%Microbial sensitivity tests
目的 探讨抗菌药物对泌尿生殖道沙眼衣原体感染者衣原体培养结果的影响,并分析药敏变化.方法 取临床经直接免疫荧光检测确定为衣原体感染者的尿道或宫颈拭子进行传代培养,碘染后发现包涵体者为培养阳性.分析患者临床用药与培养阳性及阳性代数之间的关系,并对阳性菌株进行体外药敏测试.结果 2010-2012年,共培养临床标本285份,阳性39份;未用药即培养的标本61份,阳性17份(27.87%);用药后培养224份,阳性22份(9.82%),两组阳性率比较,x2=13.22,P<0.05.未用药组阳性的17例中,1代阳性4例,2代5例,3代5例,4代2例,5代1例;用药后组阳性的22例中,2代2例,3代3例,4代9例,5代6例,6代2例,未用药与用药后培养标本首次出现沙眼衣原体包涵体的代数经秩和检验,差异有统计学意义(P<0.05),未用药标本出现阳性代数早于用药后的标本.对培养阳性的39份的标本进行体外药敏检测,结果发现,未用药患者的MIC值低于用药患者.结论 与未用药患者的标本相比,用抗菌药物患者的标本在应用细胞培养法检测衣原体时阳性率低,出现阳性者需增加传代才能检出.
目的 探討抗菌藥物對泌尿生殖道沙眼衣原體感染者衣原體培養結果的影響,併分析藥敏變化.方法 取臨床經直接免疫熒光檢測確定為衣原體感染者的尿道或宮頸拭子進行傳代培養,碘染後髮現包涵體者為培養暘性.分析患者臨床用藥與培養暘性及暘性代數之間的關繫,併對暘性菌株進行體外藥敏測試.結果 2010-2012年,共培養臨床標本285份,暘性39份;未用藥即培養的標本61份,暘性17份(27.87%);用藥後培養224份,暘性22份(9.82%),兩組暘性率比較,x2=13.22,P<0.05.未用藥組暘性的17例中,1代暘性4例,2代5例,3代5例,4代2例,5代1例;用藥後組暘性的22例中,2代2例,3代3例,4代9例,5代6例,6代2例,未用藥與用藥後培養標本首次齣現沙眼衣原體包涵體的代數經秩和檢驗,差異有統計學意義(P<0.05),未用藥標本齣現暘性代數早于用藥後的標本.對培養暘性的39份的標本進行體外藥敏檢測,結果髮現,未用藥患者的MIC值低于用藥患者.結論 與未用藥患者的標本相比,用抗菌藥物患者的標本在應用細胞培養法檢測衣原體時暘性率低,齣現暘性者需增加傳代纔能檢齣.
목적 탐토항균약물대비뇨생식도사안의원체감염자의원체배양결과적영향,병분석약민변화.방법 취림상경직접면역형광검측학정위의원체감염자적뇨도혹궁경식자진행전대배양,전염후발현포함체자위배양양성.분석환자림상용약여배양양성급양성대수지간적관계,병대양성균주진행체외약민측시.결과 2010-2012년,공배양림상표본285빈,양성39빈;미용약즉배양적표본61빈,양성17빈(27.87%);용약후배양224빈,양성22빈(9.82%),량조양성솔비교,x2=13.22,P<0.05.미용약조양성적17례중,1대양성4례,2대5례,3대5례,4대2례,5대1례;용약후조양성적22례중,2대2례,3대3례,4대9례,5대6례,6대2례,미용약여용약후배양표본수차출현사안의원체포함체적대수경질화검험,차이유통계학의의(P<0.05),미용약표본출현양성대수조우용약후적표본.대배양양성적39빈적표본진행체외약민검측,결과발현,미용약환자적MIC치저우용약환자.결론 여미용약환자적표본상비,용항균약물환자적표본재응용세포배양법검측의원체시양성솔저,출현양성자수증가전대재능검출.
Objective To investigate the effect of orally administered antimicrobial agents on the cultivation and antimicrobial susceptibility of urogenital Chlamydia trachomatis (CT).Methods Totally,285 patients with urogenital CT infection diagnosed by direct immunofluorescence from 2010 to 2012 were recruited in this study.Of them,61 patients were untreated,and 224 had received a course of regular antimicrobial treatment 5 weeks before the recruitment.Urethral or cervical swab specimens were collected from all of these patients and subjected to CT culture.The relationship of antimicrobial treatment with the culture-positive rate and the minimum number of passages required for the detection of CT inclusion bodies was assessed.In vitro susceptibility test was performed on the clinical CT isolates.Results Of the 285 clinical specimens,39 were positive for CT by cell culture.The CT culture-positive rate was 27.87% (17/61) in untreated patients and 9.82% (22/224) in treated patients (x2 =13.22,P < 0.05).Of the 17 positive specimens from untreated patients,4 were identified as positive after 1 passage of culture,5 after 2 passages,5 after 3 passages,2 after 4 passages,and 1 after 5 passages.Meanwhile,among the 22 positive specimens from treated patients,2 were identified as positive after 2 passages,3 after 3 passages,9 after 4 passages,6 after 5 passages,2 after 6 passages.Rank sum test showed that the minimum number of passages required for the detection of CT inclusion bodies was statistically lower in the specimens from untreated patients than those from treated patients (P < 0.05).The CT isolates from untreated patients showed a reduced antimicrobial sensitivity compared with those from treated patients.Conclusions Compared with the specimens taken from untreated patients,those from treated patients exhibit a lower CT culturepositive rate but an increased minimum number of passages required for the detection of CT inclusion bodies.